Because Brd2 and Brd4 expression was reduced in LDE225-treated Ptch;p53 MBs at either the RNA or protein level, we analyzed the expression levels and prognostic value of Brd2/4 in a published gene expression and survival dataset of human medulloblastoma (33). This evidence concerns the gene BRD2 and medulloblastoma.